Background: Asymptomatic carriage and spread of Extended-Spectrum Beta-Lactamase (ESBLs)-producing Enterobacteriaceae in the community are potential risk factors for transmission of infection. Objective: To determine the prevalence of ESBL resistant genes in Escherichia coli and Klebsiella pneumoniae isolated from asymptomatic out-patients. Methods: Using a questionnaire, demographic information, medical history, previous hospitalization and antibiotics used were obtained. Stool and urine samples were collected from 350 participants, cultured, and the susceptibility of the isolates to antibiotics and ESBL production were determined using the disk diffusion method. ESBL genes such as blaTEM, blaCTX, and blaSHV were identified using the Polymerase Chain Reaction. Results: Escherichia coli and Klebsiella pnuemoniae were identified from the stool samples (256; 69.9% and 89; 24.4% respectively) and urine samples (15; 4.1% and 6; 1.6% respectively). The isolates were susceptible to imipenem (330; 90.6%) and nitrofurantoin (307; 80.4%), most of the isolates were resistant to fluoroquinolones, cephalosporins, and aminoglycosides while all the isolates were resistant to ampicillin. The prevalence of ESBL was 29 (8.3%) and was observed in Escherichia coli (19; 7.0%) and Klebsiella pneumoniae (11; 12.0%), including a dual carriage. The ESBL carriers were resistant to the cephalosporins, fluoroquinolones and aminoglycosides. CTX-M (20; 66.7%), TEM (14; 46.7%), CTX-M and TEM genes co-existed in 9 (30.0%) while no SHV gene was detected in the isolates. Age, sex, prior hospitalization and antibiotics use did not predispose to ESBL carriage. Conclusion: Asymptomatic carriage of ESBL producing enterobacteria in the participants indicates that they can serve as a reservoir of the gene encoding for antibiotic resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.